Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

研究方向

Immunology/Inflammation 相关产品(4245)

  • GC50165 structure
    GC50165SM 324405
    CAS: 677773-91-0
    纯度: >98.00%

    A TLR7 agonist

  • GC50176 structure
    GC50176PMX 53
    CAS: 219639-75-5
    纯度: >98.00% / >99.50%

    PMX 53是一种高效且具有细胞渗透性和口服活性的C5a受体(CD88)拮抗剂,IC 50 值为20nM。

  • GC50190 structure
    GC50190Fenretinide - d4
    CAS: 2118244-64-5

    An internal standard for the quantification of fenretinide

  • GC50238 structure
    GC50238PMX 53c

    Negative control for PMX 53

  • GC50241 structure
    GC50241M62812
    CAS: 613263-00-6

    TLR-4 inhibitor

  • GC50242 structure
    GC50242RA 839
    CAS: 1832713-02-6

    RA 839 是 Keap1 的非共价小分子结合剂,Kd 约为 6 μM,是 Nrf2 信号传导的选择性激活剂。

  • GC50243 structure
    GC50243NFAT inhibitor, Cell Permeable
    CAS: 592517-80-1

    A cell-permeable form of NFAT inhibitor

  • GC50253 structure
    GC50253PF 543 hydrochloride
    CAS: 1706522-79-3
    纯度: >98.00%

    A potent inhibitor of SPHK1

  • GC50280 structure
    GC50280JX 06
    CAS: 729-46-4
    纯度: >99.50%

    An irreversible PDHK inhibitor

  • GC50292 structure
    GC50292c-Di-GMP sodium salt

    Endogenous STING and DDX41 agonist; activates STING-dependent signaling

  • GC50296 structure
    GC50296D9
    CAS: 1527513-89-8

    D9 是一种有效的选择性硫氧还蛋白还原酶 (TrxR) 抑制剂,EC50 为 2.8 nM。 D9 具有在体外和体内抑制肿瘤增殖的能力。

  • GC50297 structure
    GC50297RS 09
    CAS: 1449566-36-2
    纯度: >99.50%

    RS 09是一种能够激活TLR-4信号通路的合成肽。RS 09可以作为佐剂增强BALB/c小鼠的免疫反应。

  • GC50342 structure
    GC50342CP 424174
    CAS: 210825-31-3

    An inhibitor of stimulus-coupled IL-1β post-translational processing

  • GC50350 structure
    GC50350TC JL 37
    CAS: 1258294-34-6

    TC JL 37 是一种有效的、选择性的、可口服的 TYK2 抑制剂,Ki 为 1.6 nM。

  • GC50356 structure
    GC50356CL 075
    CAS: 256922-53-9
    纯度: >99.00%

    CL 075 (3M002) 是一种具有免疫调节特性的选择性 TLR8 激动剂。

  • GC50374 structure
    GC50374TH 1020
    CAS: 1841460-82-9
    纯度: >99.50%

    TH 1020是一种Toll样受体5(TLR5)/鞭毛蛋白复合物拮抗剂,IC 50 值为0.85μM。

  • GC50422 structure
    GC5042210-Cl-BBQ
    CAS: 23982-76-5

    Potent aryl hydrocarbon receptor (AhR) agonist; orally bioavailable

  • GC50511 structure
    GC50511UCLA GP130 2
    CAS: 339303-87-6
    纯度: >99.50%

    A humanin peptide mimetic

  • GC50556 structure
    GC50556NBC 19
    CAS: 2068818-75-5

    Potent NLRP3 inflammasome inhibitor

  • GC50569 structure
    GC50569NLRP3-IN-2
    CAS: 16673-34-0
    纯度: >98.50%

    An NLRP3 inflammasome inhibitor

  • GC50611 structure
    GC50611NBC 6
    CAS: 2068818-02-8
    纯度: >99.00%

    NBC 6 是一种有效的、选择性的 NLRP3 炎性体抑制剂 (IC50= 574 nM),其作用独立于 Ca2+。

  • GC50687 structure
    GC50687c-Di-AMP sodium salt
    纯度: >98.00%

    Endogenous STING and DDX41 agonist; mediates DDX41-STING interaction

  • GC52002 structure
    GC52002Emavusertib
    CAS: 1801344-14-8
    纯度: >99.00%

    An IRAK4 inhibitor

  • GC52007 structure
    GC52007N-hydroxylamine Dapsone
    CAS: 32695-27-5
    纯度: >98.00%

    An active metabolite of dapsone